Manhattan Diversion Court Evaluation Services

II. PROJECT INFORMATION UCS is the recipient of a grant (the “Grant Award”) awarded by the U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) (the “Grantor”) to provide evaluation services for the Manhattan Diversion Court, New York County, New York (the “Project”). Pursuant to the terms of the Grant Award, $200,000 is the maximum available funding for Project Services (as set forth in Article V below) performed during October 15, 2024 – September 29, 2029, provided, however, that such period may be extended upon mutual agreement of Grantor and UCS (the “Project Term”). UCS reserves the right to request a no-cost extension of the Project Term from the Grantor. UCS anticipates that the selected applicant will be designated a “subrecipient” rather than a “contractor” for purposes of federal requirements of the Grant Award. III. AWARD UCS intends to award one contract for a term commencing on or about October 15, 2024, and terminating on or about September 29, 2029 (“Contract Term”). Awarded contractor shall be contractually obligated to provide the Project Services (as described below) for the Project Term, as it may be amended or extended. UCS and awarded contractor shall communicate regularly concerning the remaining amount of grant funds and the approximate timing of complete expenditure IV. MINIMUM QUALIFICATIONS Proposals will be considered only from applicants who meet the following minimum qualifications: Individuals or organizations with at least three (3) years of experience performing service relevant to those described herein. V. PROJECT SERVICES UCS seeks proposals describing how the applicant will provide the services listed below (“Project Services”). The selected applicant shall be required to: 1. Design a process and outcome evaluation plan in collaboration with the Manhattan Diversion Court; 2. Develop evaluation instruments to ensure collection of all data required to monitor grant-related goals and objectives; 3. Review current databases to ensure all necessary quantitative and qualitative data is collected; 4. Assist the Manhattan Diversion Court in collecting and compiling data for continuous quality assurance improvement for the participant intake process, integration of substance use disorder counseling, service delivery, program completion rates, and effectiveness in reducing recidivism; 5. Ensure all necessary quantitative and qualitative data are collected for quarterly and annual evaluation reports and as required by Substance Abuse and Mental Health Services Administration (SAMHSA) for periodic reporting pursuant to the Government Performance and Results Act (GPRA).  6. Assist the Manhattan Diversion Court on an ongoing basis to track participants to ensure GPRA court-client outcome data is being collected at the appropriate points in time as required by SAMHSA.  7. Prepare quarterly and annual evaluation reports that include analyses of outcome and process findings and provide such reports to the Project’s workgroup. 8. Complete monthly, quarterly, bi-annual and/or annual reports as required to SAMHSA. 9. Provide feedback to the Manhattan Diversion Court on an ongoing basis to promote continuous quality improvement and make recommendations for data-informed policy changes; and 10. Produce a final program evaluation report.   Key Bid Dates: Bid Issue Date (Date it needs to go live): 9/10/24 Question Due Date: 9/24/24 at 2:00PM Bids Due: 10/8/24 at 2:00PM Service-Disabled Veteran-Owned Set Aside: No Due date:10/08/2024 2:00 PM Contract term: 10/15/2024-09/29/2029 County(ies): New York Location: Manhattan Business entities awarded an identical or substantially similar procurement contract within the past five years: Christina Carver Pratt DBA Just World Media; Julie Raines; Keuka College; New York University; Research Foundation of SUNY; SAE & Associates; Stony Brook Research and Evaluation Consulting; Susan Adair; Teacher's College, Columbia University; UB Family Medicine Inc; Via Evaluation